Bromocriptine Mesylate and Tafenoquine (Prevention of Malaria Relapse)
Determining the interaction of Bromocriptine Mesylate and Tafenoquine (Prevention of Malaria Relapse) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromocriptine
Brand name: Parlodel, Cycloset
Synonyms: Bromocriptine
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromocriptine Mesylate-Tafenoquine Succinate (Arakoda)
- Bromocriptine Mesylate-Tafenoquine Succinate (Krintafel)
- Bromocriptine Mesylate-Tafinlar
- Bromocriptine Mesylate-Tafluprost
- Bromocriptine Mesylate-Tafluprost ophthalmic
- Bromocriptine Mesylate-Tagamet
- Tafenoquine (Prevention of Malaria Relapse)-Brompheniramine
- Tafenoquine (Prevention of Malaria Relapse)-Brompheniramine and codeine
- Tafenoquine (Prevention of Malaria Relapse)-Brompheniramine and phenylephrine
- Tafenoquine (Prevention of Malaria Relapse)-Brompheniramine and Phenylephrine Chewable Tablets
- Tafenoquine (Prevention of Malaria Relapse)-Brompheniramine and Phenylephrine Liquid
- Tafenoquine (Prevention of Malaria Relapse)-Brompheniramine and Phenylephrine Suspension